Abstract
Modification of A ring of 10-deacetylbaccatin III to get novel rearranged taxoids is described. The modification is achieved via manoeuvering of the C-11 double bond of 10-deacetylbaccatin III.
Keywords: 10-deacetylbaccatin III, rearranged taxoids, Taxus baccata var, Wallichiana, m-chloroperbenzoic acid (m-CPBA)
Letters in Organic Chemistry
Title: Modification of Taxane A Ring via Manoeuvering of the C-11 Double Bond of 10-Deacetylbaccatin III to Get Novel Rearranged Taxoids
Volume: 5 Issue: 8
Author(s): Vaishali Chakraborty and Manobjyoti Bordoloi
Affiliation:
Keywords: 10-deacetylbaccatin III, rearranged taxoids, Taxus baccata var, Wallichiana, m-chloroperbenzoic acid (m-CPBA)
Abstract: Modification of A ring of 10-deacetylbaccatin III to get novel rearranged taxoids is described. The modification is achieved via manoeuvering of the C-11 double bond of 10-deacetylbaccatin III.
Export Options
About this article
Cite this article as:
Chakraborty Vaishali and Bordoloi Manobjyoti, Modification of Taxane A Ring via Manoeuvering of the C-11 Double Bond of 10-Deacetylbaccatin III to Get Novel Rearranged Taxoids, Letters in Organic Chemistry 2008; 5 (8) . https://dx.doi.org/10.2174/157017808786857543
DOI https://dx.doi.org/10.2174/157017808786857543 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Advancement of Targeted Ultrasound Contrast Agents and their Applications in Molecular Imaging and Targeted Therapy
Current Pharmaceutical Design ABC Multidrug Transporters: Target for Modulation of Drug Pharmacokinetics and Drug-Drug Interactions
Current Drug Targets Mesothelioma - Update on Management
Current Respiratory Medicine Reviews Aromatase, Estrogens and Testicular Germ Cell Development
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Vandetanib, A Dual Inhibitor of VEGFR and EGFR Tyrosine Kinase Activity
Current Cancer Therapy Reviews Supramolecular Nanomedicine - An Overview
Current Drug Targets Optimizing Target Selection and Development Strategy in Cancer Treatment; The Next Wave
Current Medicinal Chemistry - Anti-Cancer Agents Review: The JAK/STAT Protein Activation – Role in Cancer Development and Targeted Therapy
Current Signal Transduction Therapy Synthesis and Biological Evaluation of 1,3,4-Thiadiazole Linked Phthalimide Derivatives as Anticancer Agents
Letters in Drug Design & Discovery Inflammation and Immunology of the Vitreoretinal Compartment
Inflammation & Allergy - Drug Targets (Discontinued) Critical Role of IL-8 Targeting in Gliomas
Current Medicinal Chemistry Application of Proteome Analysis to the Assessment of Prognosis and Response Prediction in Clinical Oncology
Current Cancer Drug Targets In Vitro Evaluation of Antimicrobial and Antiproliferative Activities for Compounds Isolated from the Ficus Bubu Warb. (Moraceae) Fruits: Chemotaxonomic Significance
Drug Delivery Letters Investigation Binding Patterns of Human Carboxylesterase I (hCES I) with Broad Substrates by MD Simulations
Current Topics in Medicinal Chemistry Vanilloid Receptor Antagonists: Emerging Class of Novel Anti-Inflammatory Agents for Pain Management
Current Pharmaceutical Design TGF-Beta: a Master Switch in Tumor Immunity
Current Pharmaceutical Design Three Decades of P-gp Inhibitors: Skimming Through Several Generations and Scaffolds
Current Medicinal Chemistry Tackling Cardiovascular Risk: New Evidence from Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies
Current Cancer Drug Targets Current Treatment Concepts of CML
Current Cancer Drug Targets